Compare American Well Corp (AMWL) vs MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Well Corp vs MONDELEZ INTERNATIONAL INC Common Stock — how do they compare? American Well Corp trades at $9.61 (market cap $165.58M), while MONDELEZ INTERNATIONAL INC Common Stock trades at $59.32 (market cap $75.52B). The key difference: MONDELEZ INTERNATIONAL INC Common Stock is far larger — about 456.1× American Well Corp's market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.4% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | MDLZ | |
|---|---|---|
Market Cap | $165.58M | $75.52B |
Sector | Health | Consumer Staples |
52-Week High | $9.91 | $70.75 |
52-Week Low | $3.78 | $51.51 |
Enterprise Value | -$9.66M | $95.62B |
Dividend Yield | — | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
Mondelez International (MDLZ) trades at $58.83, up 0.91% today, with a bearish technical signal but strong analyst consensus. The stock shows consistent earnings beats in recent quarters, with Q2 2026 EPS expected at $0.67. Revenue grew to $38.54B in 2025, though net income margin compressed to 6.64%. Recent news highlights innovation in packaging and new product launches, alongside a stable dividend of $0.50 per share.
The outlook remains positive with a consensus price target of $68.33, implying 16% upside. Key opportunities include resilient snacking demand and strategic innovations, while risks involve margin pressure from input costs and competitive intensity. Institutional sentiment is bullish, but technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About MONDELEZ INTERNATIONAL INC Common Stock
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →
